1. U.S. Food and Drug Administration. Statement from FDA Commissioner Scott Gottlieb, M.D. and Peter Marks, M.D., Ph.D., Director of the Center for Biologics Evaluation and Research on new policies to advance development of safe and effective cell and gene therapies, https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-and-peter-marks-md-phd-director-center-biologics; 2019 [accessed 15.9.20].
2. Arizton. Cell & Gene Therapy Market - Global Outlook and Forecast 2020-2025, https://www.researchandmarkets.com/reports/5135120/cell-and-gene-therapy-market-global-outlook-and; 2020 [accessed 15.9.20].
3. Risk in vaccine research and development quantified;Pronker;PLoS One,2013
4. ModernaTX, Inc. A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19, https://clinicaltrials.gov/ct2/show/NCT04470427; 2020 [accessed 15.9.20].
5. BioNTech SE. Study to describe the safety, tolerability, immunogenicity, and efficacy of rna vaccine candidates against COVID-19 in healthy adults, https://clinicaltrials.gov/ct2/show/NCT04368728; 2020 [accessed 15.9.20].